PAR 2.00% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Presentation for Investor Webinar, page-4

  1. 2,137 Posts.
    lightbulb Created with Sketch. 574
    R&D Day 2020 - tells market 002 study will conclude end Q1 2023.
    006 study to conclude Q3 2023.

    Gets 7 months of FDA IND delays. Tells market that they will initiate new sites to make up delay time.

    Drops presentation to say 002 and 006 will be 18 months delay.

    You can't make this stuff up.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.005(2.00%)
Mkt cap ! $85.70M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $187.1K 755.0K

Buyers (Bids)

No. Vol. Price($)
2 47906 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 13363 1
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.